Malignant melanoma in organ transplant recipients

Skin Disease in Organ Transplantation

Volumn , Issue , 2008, Pages 182-189

  Christenson, Leslie J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957000970     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511547379.030     Document Type: Chapter

References (35)

1. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, et al. Germline p16 mutations in familial melanoma. Nat Genet. 1994;8:15–21.
2. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet. 1996;12:97–9.
3. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002 Jun 27;417:949–54. Epub 2002 Jun 9.
4. Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal-transplant recipients. Lancet. 1981;1:1196–9.
5. Penn I. Malignant melanoma in organ allograft recipients. Transplantation. 1996;61:274–8.
6. Leveque L, Dalac S, Dompmartin A, Louvet S, Euvrard S, Catteau B, et al. Melanoma in organ transplant patients [French]. Ann Dermatol Venereol. 2000;127:160–5.
7. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol. 2006;154: 472–7.
8. National Cancer Institute [homepage on the Internet]. 51-Year trends in U.S. cancer death rates [cited 2006 Apr 10]. Available from: http://seer.cancer.gov/csr/1975_2000/results_merged/topic_inc_mortrends.pdf.
9. Penn I. Transmission of cancer from organ donors. Ann Transplant. 1997;2:7–12.
10. Penn I. Transmission of cancer from organ donors [short survey]. Nefrologia. 1995;15:205–13.
11. Stephens JK, Everson GT, Elliott CL, Kam I, Wachs M, Haney J, et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation. 2000;70:232–6.
12. Birkeland SA, Storm HH. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation. 2002;74:1409–13.
13. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation. 2000;70: 1747–51.
14. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Derma-tol. 2000;143:513–9.
15. Hollenbeak CS, Todd MM, Billingsley EM, Harper G, Dyer AM, Lengerich EJ. Increased incidence of melanoma in renal transplantation recipients. Cancer. 2005;104:1962–7.
16. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, et al. Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer. 1995;60:183–9.
17. Penn I. De novo malignancies in pediatric organ transplant recipients. Pediatr Transplant. 1998;2:56–63.
18. Sheil AG. Donor-derived malignancy in organ transplant recipients. Transplant Proc. 2001;33:1827–9.
19. Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG, et al. Aggressive cutaneous malignancies following car-diothoracic transplantation: the Australian experience. Cancer. 1999;85:1758-64.
20. Sheil AG, Flavel S, Disney AP, Mathew TH, Hall BM. Cancer incidence in renal transplant patients treated with azathioprine or cyclo-sporine. Transplant Proc. 1987;19:2214-6.
21. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation. 1996;61:715-21.
22. Smith CH, McGregor JM, Barker JN, Morris RW, Rigden SP, MacDonald DM. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol. 1993;28:51-5.
23. Szepietowski J, Wasik F, Szepietowski T, Wlodarczyk M, Sobczak-Radwan K, Czyz W. Excess benign melanocytic naevi in renal transplant recipients. Dermatology. 1997;194:17-9.
24. MacKie RM, Reid R, Junor B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med. 2003;348:567-8.
25. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-34.
26. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001; 19: 3635-48.
27. Morris-Stiff G, Steel A, Savage P, Devlin J, Griffiths D, Portman B, et al, Welsh Transplantation Research Group. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant. 2004;4:444-6.
28. Elder GJ, Hersey P, Branley P. Remission of transplanted melanoma: clinical course and tumour cell characterisation. Clin Transplant. 1997;11:565-8.
29. Buell JF, Trofe J, Hanaway MJ, Lo A, Rosengard B, Rilo H, et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery. 2001;130:660-6.
30. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Harden PN. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol. 2002;147:950-6.
31. Webb MC, Compton F, Andrews PA, Koffman CG Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplant Proc. 1997;29:828-30.
32. Otley CC, Berg D, Ulrich C, Stasko T, Murphy GM, Salasche SJ, et al, Reduction of Immunosuppression Task Force of the International Transplant Skin Cancer Collaborative and the Skin Care in Organ Transplant Patients Europe. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol. 2006;154:395-400.
33. Suranyi MG, Hogan PG, Falk MC, Axelsen RA, Rigby R, Hawley C, et al. Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. Transplantation. 1998;66:655-61.
34. Loren AW, Desai S, Gorman RC, Schuchter LM. Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma. Transplantation. 2003;76:741-3.
35. Sorscher SM. Withdrawal of immunosuppressive therapy after developing melanoma. J Am Acad Dermatol. 2004;50:802.